Virax Biolabs Group Limited (VRAX) Return on Investment ROI from the fourth quarter of 2024 to fourth quarter of and for the year 2024, average high and low, overall ranking from Mar 31 2024 to - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Virax Biolabs Group Limited  (NASDAQ: VRAX)


Virax Biolabs Group Limited's ROI from its fourth quarter of 2024 to the fourth quarter of and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Virax Biolabs Group Limited's ROI in the fourth quarter of 2024?


Within the Healthcare sector 786 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2024 from 0 to 4562.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Investment Change TTM 112.96 % 261.42 % - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 6 5 9 5 5
Return On Investment (TTM) 0 % 0 % 0 % 0 % 0 %
VRAX's Overall Ranking # 4562 # 0 # 0 # 0 #
Seq. Investment Change TTM 4.47 % -12.62 % 55.08 % 50.42 % 77.31 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 0 0 0 0 0

VRAX Company Profile >> Back to VRAX Roi Comparisons >> See Annual VRAX Return On Investment



Return On Investment VRAX's Ranking
Within: No.
Industry # 12
Sector # 787
Overall # 4562

Return On Investment Statistics
High Average Low
-61.3 %
-99.72 %
-126.79 %
(Mar 31 2023)   (Mar 31 2024)







Financial Statements
Virax Biolabs Group Limited's IV. Quarter Investments $ 6 Millions VRAX's Balance sheet
Virax Biolabs Group Limited's IV. Quarter Income $ 0 Millions Quarterly VRAX's Income Statement
VRAX's Income by Division See VRAX's Income by Division


VRAX Annual Return On Investment (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2021)
2022
Total Investments in Millions 5 5 9 -1 0
Y / Y Investment Growth 2.77 % -40.31 % - - -
Net Income in Millions -6 -7 -5 -2 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -111.08 % -126.79 % -61.3 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
In Vitro & In Vivo Diagnostic Substances Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VRAX's Roi Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VRAX's Competitors
Subscribers only: Roi for Virax Biolabs Group Limited's Suppliers
Subscribers only: Return On Investment for VRAX's Customers

Other Ratios
VRAX's Roa VRAX's Inventory Turnover Ratio VRAX's Growth Rates VRAX's Dividend Statistics
VRAX's Profitability Ratios VRAX's Asset Turnover Ratio VRAX's Dividend Growth
VRAX's Roe VRAX's Valuation Ratios VRAX's Financial Strength Ratios VRAX's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2024, within Healthcare Sector ROI

Date modified: 2024-10-22T17:06:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.